Cargando…

HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trial

BACKGROUND: Oral emtricitabine-tenofovir disoproxil fumarate (FTC/TDF) pre-exposure prophylaxis (PrEP) is used to prevent the sexual acquisition of HIV. Transgender women (TGW) have unique characteristics that may relate to PrEP use, effectiveness, and safety. METHODS: The iPrEx trial was a randomiz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deutsch, Madeline B., Glidden, David V., Sevelius, Jae, Keatley, Joanne, McMahan, Vanessa, Guanira, Juan, Kallas, Esper G., Chariyalertsak, Suwat, Grant, Robert M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111857/ https://www.ncbi.nlm.nih.gov/pubmed/26614965 http://dx.doi.org/10.1016/S2352-3018(15)00206-4

Ejemplares similares

HIV-1 Drug Resistance in the iPrEx Preexposure Prophylaxis Trial
por: Liegler, Teri, et al.
Publicado: (2014)

No Evidence of Sexual Risk Compensation in the iPrEx Trial of Daily Oral HIV Preexposure Prophylaxis
por: Marcus, Julia L., et al.
Publicado: (2013)

Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis
por: Grant, Robert M., et al.
Publicado: (2016)

Syphilis Predicts HIV Incidence Among Men and Transgender Women Who Have Sex With Men in a Preexposure Prophylaxis Trial
por: Solomon, Marc M., et al.
Publicado: (2014)

Brief Report: HIV-1 gp120 T-Cell Responses Correspond to Infection Outcomes in the Global iPrEx Chemoprophylaxis Trial
por: Kuebler, Peter J., et al.
Publicado: (2016)

Uptake, Retention, and Adherence to Pre-exposure Prophylaxis (PrEP) in TRIUMPH: A Peer-Led PrEP Demonstration Project for Transgender Communities in Oakland and Sacramento, California
por: Sevelius, Jae M., et al.
Publicado: (2021)

Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
por: Solomon, Marc M., et al.
Publicado: (2014)

Evaluating the impact of policies recommending PrEP to subpopulations of men and transgender women who have sex with men based on demographic and behavioral risk factors
por: Janes, Holly, et al.
Publicado: (2019)

The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices
por: Sevelius, Jae M, et al.
Publicado: (2016)

The Safety of Tenofovir–Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B
por: Solomon, Marc M., et al.
Publicado: (2016)

1285. PrEP Acceptability, Uptake, and Adherence Among Young Men Who Have Sex with Men and Transgender Women in PrEP Demonstration Project, Chiang Mai, Thailand
por: Kaewpoowat, Quanhathai, et al.
Publicado: (2019)

Acceptability of Pre-Exposure Prophylaxis among Men Who Have Sex with Men and Transgender Women in Northern Thailand
por: Yang, Daniel, et al.
Publicado: (2013)

Depression and Oral FTC/TDF Pre-exposure Prophylaxis (PrEP) Among Men and Transgender Women Who Have Sex With Men (MSM/TGW)
por: Defechereux, Patricia A., et al.
Publicado: (2015)

“Entre Nosotras:” a qualitative study of a peer-led PrEP project for transgender latinas
por: Zamudio-Haas, Sophia, et al.
Publicado: (2023)

Inclusion as illusion: erasing transgender women in research with MSM
por: Poteat, Tonia C, et al.
Publicado: (2021)

Electronic medical records and the transgender patient: recommendations from the World Professional Association for Transgender Health EMR Working Group
por: Deutsch, Madeline B, et al.
Publicado: (2013)

“She is Like a Sister to Me.” Gender-Affirming Services and Relationships are Key to the Implementation of HIV Care Engagement Interventions with Transgender Women of Color
por: Maiorana, Andres, et al.
Publicado: (2020)

Transgender women, hormonal therapy and HIV treatment: a comprehensive review of the literature and recommendations for best practices
por: Radix, Asa, et al.
Publicado: (2016)

Self-reported Recent PrEP Dosing and Drug Detection in an Open Label PrEP Study
por: Amico, K. Rivet, et al.
Publicado: (2016)

A comparison of attitudes and knowledge of pre-exposure prophylaxis (PrEP) between hospital and Key Population Led Health Service providers: Lessons for Thailand’s Universal Health Coverage implementation
por: Rayanakorn, Ajaree, et al.
Publicado: (2022)

PrEP stigma among current and non-current PrEP users in Thailand: A comparison between hospital and key population-led health service settings
por: Chautrakarn, Sineenart, et al.
Publicado: (2022)

HIV Incidence, Risk Factors, and Motivation for Biomedical Intervention among Gay, Bisexual Men, and Transgender Persons in Northern Thailand
por: Chariyalertsak, Suwat, et al.
Publicado: (2011)

Mental Health and Psychosocial Risk and Protective Factors Among Black and Latinx Transgender Youth Compared With Peers
por: Vance, Stanley Ray, et al.
Publicado: (2021)

Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study
por: Marins, Luana M. S., et al.
Publicado: (2019)

Comparing Substance Use and School-Based Stressors Among Black and Latinx Transgender Youth and Peers With Shared Minoritized Identities
por: Vance, Stanley R., et al.
Publicado: (2023)

An evaluation of nine culturally tailored interventions designed to enhance engagement in HIV care among transgender women of colour in the United States
por: Rebchook, Gregory M., et al.
Publicado: (2022)

High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project
por: Hoagland, Brenda, et al.
Publicado: (2017)

HIV Testing and PrEP Use in a National Probability Sample of Sexually Active Transgender People in the United States
por: Sevelius, Jae M., et al.
Publicado: (2020)

From trials to the public health: pre-exposure prophylaxis for HIV prevention
por: Kallas, Esper Georges, et al.
Publicado: (2013)

Exploring barriers and facilitators to PrEP use among transgender women in two urban areas: implications for messaging and communication
por: Bass, Sarah Bauerle, et al.
Publicado: (2022)

Factors associated with long‐term HIV pre‐exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study
por: Konda, Kelika A., et al.
Publicado: (2022)

Transgender social inclusion and equality: a pivotal path to development
por: Divan, Vivek, et al.
Publicado: (2016)

High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women
por: Carballo-Diéguez, Alex, et al.
Publicado: (2017)

Determinants of Pre-exposure Prophylaxis (PrEP) Implementation in Transgender Populations: A Qualitative Scoping Review
por: Zamantakis, Alithia, et al.
Publicado: (2022)

Considerations for the Design of Pre-exposure Prophylaxis (PrEP) Interventions for Women: Lessons Learned from the Implementation of a Novel PrEP Intervention
por: Walters, Suzan M., et al.
Publicado: (2021)

Evidence for action: a call for the global HIV response to address the needs of transgender populations
por: Poteat, Tonia C, et al.
Publicado: (2016)

Pre-Exposure Prophylaxis (PrEP) for HIV Infection in Cisgender and Transgender Women in the U.S.: A Narrative Review of the Literature
por: Baldwin, Aleta, et al.
Publicado: (2021)

HIV pre-exposure prophylaxis and health and community systems in the Global South: Thailand case study
por: Colby, Donn, et al.
Publicado: (2015)

Integrated and Gender-Affirming Transgender Clinical Care and Research
por: Reisner, Sari L., et al.
Publicado: (2016)

1279. Barriers to Acquiring Pre-Exposure Prophylaxis (PrEP), Risk Factors for HIV and Health Determinants in Adult Transgender Individuals
por: Sanchez, Daniel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bakh4jphropjnedea0f0li214m